Nephrocare Health IPO GMP Today
The Nephrocare Health IPO GMP is ₹40 (+8.7% over the upper price band of ₹460) as of 17 Dec 2025, giving an estimated listing price of ₹500 per share. On a minimum application of 32 shares, that is an estimated gain of ₹1,280. GMP has risen by ₹40 since tracking began on 4 Dec.
Last updated
- Issue Price
- ₹460
- GMP
- ₹40
- GMP %
- +8.7%
- Est. listing
- ₹500
- Est. gain / application
- +₹1,280
Nephrocare Health IPO GMP trend
Tracked for 15 days. High ₹40 on 17 Dec, low ₹0 on 4 Dec.
Nephrocare Health IPO GMP day-wise
| Date | GMP | Change | GMP % | Est. listing | Est. gain (32 sh) |
|---|---|---|---|---|---|
| (latest) | ₹40 | +₹3 | 8.70% | ₹500 | +₹1,280 |
| ₹37 | 0 | 8.04% | ₹497 | +₹1,184 | |
| ₹37 | +₹3 | 8.04% | ₹497 | +₹1,184 | |
| ₹34 | +₹1 | 7.39% | ₹494 | +₹1,088 | |
| ₹33 | 0 | 7.17% | ₹493 | +₹1,056 | |
| ₹33 | +₹22 | 7.17% | ₹493 | +₹1,056 | |
| ₹11 | -₹9 | 2.39% | ₹471 | +₹352 | |
| ₹20 | +₹20 | 4.35% | ₹480 | +₹640 | |
| ₹0 | 0 | 0.00% | ₹460 | ₹0 | |
| ₹0 | 0 | 0.00% | ₹460 | ₹0 | |
| ₹0 | 0 | 0.00% | ₹460 | ₹0 | |
| ₹0 | 0 | 0.00% | ₹460 | ₹0 | |
| ₹0 | 0 | 0.00% | ₹460 | ₹0 | |
| ₹0 | 0 | 0.00% | ₹460 | ₹0 | |
| ₹0 | — | 0.00% | ₹460 | ₹0 |
Est. listing = upper price band (₹460) + GMP. Est. gain = GMP × 32 shares (1 lot, the minimum application).
Nephrocare Health IPO subscription status
| QIB | 27.47x |
|---|---|
| bNII | 29.81x |
| sNII | 13.19x |
| Retail | 2.31x |
| Total | 13.96x |
Reading the Nephrocare Health IPO GMP
The grey market premium is the price above the issue price at which Nephrocare Health IPO shares are informally traded before listing. A GMP of ₹40 on an upper band of ₹460 suggests the shares could open around ₹500, if grey market sentiment holds until listing day.
GMP is not set by the company, the exchanges or SEBI. It moves daily with market conditions and subscription demand. Check it together with the subscription numbers and the company's financials before applying.
Nephrocare Health IPO GMP: FAQs
- What is Nephrocare Health IPO GMP today?
- The latest grey market premium (GMP) for the Nephrocare Health IPO is ₹40 as of 17 December 2025, which is 8.70% over the upper price band of ₹460.
- What is the expected listing price of Nephrocare Health IPO?
- Based on the current GMP, the estimated listing price of Nephrocare Health IPO is ₹500 per share (₹460 issue price + ₹40 GMP). This is an estimate from unofficial grey market trades, not a guaranteed listing price.
- What is the lot size and minimum investment for Nephrocare Health IPO?
- The lot size is 32 shares. The minimum application is 1 lot, which costs ₹14,720 at the upper price band.
- Is IPO GMP reliable?
- GMP reflects unofficial trades before listing and changes daily with market mood and subscription demand. It is a useful sentiment indicator but often differs from the actual listing price, so use it alongside the company's financials and subscription data.
GMP is an unofficial indicator compiled from grey market sources and is not investment advice. Actual listing prices can differ significantly. Read the offer document before investing.